Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
37%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING HOLDINGS
MEDX
28
HOLDINGS
39%
ALSO IN XLV
XLV
60
HOLDINGS
18%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus XLV)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in XLV
Overlap
ELI LILLY & CO 16.4% 12.5% 12.5%
ABBVIE INC 8.8% 6.6% 6.6%
JOHNSON & JOHNSON 4.8% 7.5% 4.8%
MERCK & CO. INC. 3.4% 4.1% 3.4%
AMGEN INC 5.9% 3.1% 3.1%
MEDX Overweight Relative to XLV
NOVARTIS AG-ADR 7.3%
ALNYLAM PHARMACEUTICALS INC 5.9%
ASTRAZENECA PLC-SPONS ADR 5.5%
ALKERMES PLC 4.2%
ELI LILLY & CO 3.9%
BRISTOL-MYERS SQUIBB CO 3.2%
CRISPR THERAPEUTICS AG 3.2%
IONIS PHARMACEUTICALS, INC. 3.1%
AMGEN INC 2.8%
GLAXOSMITHKLINE PLC-SPON ADR 2.7%
MEDX Underweight Relative to XLV
UNITEDHEALTH GROUP INC -5.8%
ABBOTT LABORATORIES -4.8%
INTUITIVE SURGICAL INC -3.9%
BOSTON SCIENTIFIC CORP -3.2%
THERMO FISHER SCIENTIFIC INC -3.2%
GILEAD SCIENCES INC -2.8%
STRYKER CORP -2.8%
JOHNSON & JOHNSON -2.7%
DANAHER CORP -2.6%
VERTEX PHARMACEUTICALS INC -2.3%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY